List view / Grid view
27 November 2012 | By Gilead Sciences
Gilead Sciences announced topline results from the Phase 3 POSITRON study...
26 November 2012 | By GlaxoSmithKline
GSK and GSK Nigeria have reached agreement...
20 November 2012 | By Novartis
The US FDA approved the use of Flucelvax®...
20 November 2012 | By GlaxoSmithKline
GSK will be a headline partner at the Coronation Festival...
20 November 2012 | By Bristol-Myers Squibb Company
The EC has approved ELIQUIS®...
Jean-Marc Pardonge, 52 years old, has been appointed as the new President of Aptar Pharma’s Prescription Division, world leader in the development and manufacturing of nasal and pulmonary drug delivery devices.
19 November 2012 | By Cystic Fibrosis Foundation
CFFT announced a major expansion of its research collaboration with Pfizer...
19 November 2012 | By GlaxoSmithKline
GlaxoSmithKline plc announced that the U.S. FDA has approved PROMACTA for the treatment of thrombocytopenia...
19 November 2012 | By Pfizer
Top-line results of a Phase 3 study...
17 November 2012 | By Roche
Results from positive phase III AVAglio study...
16 November 2012 | By kdm communications limited
LGC Standards’ LoGiCal® reference materials are proving a valuable resource for scientists at the Institute of Forensic Research...
16 November 2012 | By Sanofi
“We are pleased that CHMP has supported our ZALTRAP application..."
16 November 2012 | By Sanofi
“The CHMP positive opinion for Lyxumia marks an important milestone..."
16 November 2012 | By Novartis
The CHMP of the EMA adopted a positive opinion for Exjade®...
16 November 2012 | By GlaxoSmithKline
Results from the first randomised controlled European clinical trial...
